======= MED31 ======= == Gene Information == * **Official Symbol**: MED31 * **Official Name**: mediator complex subunit 31 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51003|51003]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y3C7|Q9Y3C7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MED31&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MED31|Open PubMed]] * **OMIM**: [[https://omim.org/entry/620492|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. |Med31| |core mediator complex| |negative regulation of fibroblast proliferation| |mediator complex| |regulation of fibroblast proliferation| |ubiquitin ligase complex| |transcription initiation from RNA polymerase II promoter| |appendage development| |limb development| |DNA-templated transcription, initiation| |ubiquitin protein ligase activity| |transcription coactivator activity| |transcription by RNA polymerase II| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |negative regulation of cell population proliferation| |protein ubiquitination| |protein modification by small protein conjugation| |protein modification by small protein conjugation or removal| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |regulation of cell population proliferation| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp470|Chloroquine 32μM R08 exp470]]|-2.28| |[[:results:exp452|Azithromycin 100μM R08 exp452]]|-1.83| |[[:results:exp270|Campthothecin 0.001μM R06 exp270]]|-1.83| |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|-1.83| |[[:results:exp341|BRD2 inhibitor II 20μM R07 exp341]]|-1.8| |[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|-1.78| |[[:results:exp121|Golgicide-A 2μM R03 exp121]]|-1.75| ^Gene^Correlation^ |[[:human genes:m:med16|MED16]]|0.404| Global Fraction of Cell Lines Where Essential: 3/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|1/20| |lung|0/75| |lymphocyte|1/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3721 * **Expression level (log2 read counts)**: 3.2 {{:chemogenomics:nalm6 dist.png?nolink |}}